Ligase-mediated programmable genomic integration (L-PGI).

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• CRISPR systems are versatile tools for programmable genomic editing.
• Current methods like Cas9 nickase with reverse transcriptase have limitations, especially in post-mitotic cells.
• These limitations hinder in vivo applications and translatability.

Purpose of the Study:

• To develop a novel ligase-based gene editing method.
• To overcome the limitations of existing CRISPR-based editing techniques, particularly in challenging cell types.
• To demonstrate the efficacy and applicability of this new method in various biological systems.

Main Methods:

• Utilizing Cas9 nickase to create targeted genomic nicks.
• Employing a ligase-based approach for the delivery and integration of synthetic DNA donors.
• Testing the method in cell lines, primary cell cultures, and adult mice using nonviral delivery.

Main Results:

• Demonstrated editing activity in diverse cell types, including primary cells and in vivo models.
• Achieved favorable on-target editing outcomes compared to transcription-based methods.
• Showcased good tolerability and efficient nonviral deliverability of the editing components.

Conclusions:

• The novel ligase-mediated gene editing method offers a promising alternative for precise genomic modifications.
• This approach addresses limitations of previous technologies, enhancing applicability in post-mitotic cells and in vivo.
• Ligation-mediated gene editing holds significant potential for advancing genomic medicine and therapeutic applications.